Home
>
National Drug Code (NDC)
>
Haloperidol
Haloperidol - 0378-0335-01 - (haloperidol)
Drug Information of Haloperidol
| Product NDC: | 0378-0335 |
| Proprietary Name: | Haloperidol |
| Non Proprietary Name: | haloperidol |
| Active Ingredient(s): | 20 mg/1 & nbsp; haloperidol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Haloperidol
| Product NDC: | 0378-0335 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070278 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120905 |
Package Information of Haloperidol
| Package NDC: | 0378-0335-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0335-01) |
NDC Information of Haloperidol
| NDC Code | 0378-0335-01 |
| Proprietary Name | Haloperidol |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0335-01) |
| Product NDC | 0378-0335 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | haloperidol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120905 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | HALOPERIDOL |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |
